Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Susan V McCluskey"'
Publikováno v:
International journal of pharmaceutical compounding. 21(5)
The stability of dalteparin 1,000 units/mL in 0.9% sodium chloride for injection stored in polypropylene syringes under refrigeration was examined. Dalteparin 1,000-units/mL syringes were prepared by adding 9 mL of 0.9% sodium chloride for injection
Publikováno v:
International journal of pharmaceutical compounding. 21(2)
The stability of alprostadil diluted in 0.9% sodium chloride stored in polyvinyl chloride (VIAFLEX) containers at refrigerated temperature, protected from light, is reported. Five solutions of alprostadil 11 mcg/mL were prepared in 250 mL 0.9% sodium
Publikováno v:
American Journal of Health-System Pharmacy. 65:1266-1269
Purpose. A collaborative effort between two pharmacy specialty areas for ensuring compliance with United States Pharmacopeia ( USP ) chapter 797 for compounded sterile preparations (CSPs) is described. Summary. In September 2005, an investigational d
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 72(15)
Purpose The stability of a solution of chlorothiazide injection diluted with sterile water and stored in polypropylene syringes under refrigerated conditions was investigated. Methods Chlorothiazide solutions were compounded by adding 20 mL of steril
Autor:
Susan V, McCluskey, Matthew D, Sztajnkrycer, Donald A, Jenkins, Scott P, Zietlow, Kathleen S, Berns, Myung S, Park
Publikováno v:
International journal of pharmaceutical compounding. 18(5)
Tranexamic acid has recently been demonstrated to decrease all-cause mortality and deaths due to hemorrhage in trauma patients. The optimal administration of tranexamic acid is within one hour of injury, but not more than three hours from the time of
Publikováno v:
International journal of pharmaceutical compounding. 17(6)
Various angiography procedures at Mayo Clinic (Rochester campus) require small bolus doses of injectable nitroglycerin. Commercially acquired containers of injectable nitroglycerin provide excessive amounts of drug for these procedural needs, so syri
Autor:
Susan V, McCluskey, Gregory J, Brunn
Publikováno v:
International journal of pharmaceutical compounding. 15(2)
The purpose of this study was to evaluate nifedipine oral and topical compounding formulas and procedures. Topical preparations were compounded in Plastibase 50 W, using combinations of two drug sources and four types of light exposure. Oral preparat
Autor:
Nicole Vu, Jesse Kemp, Kevin K. Graner, Michel Ben, Vasileios Aloumanis, Thomas C Kupiec, Susan V. McCluskey
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 66(9)
Purpose. The stability of fentanyl 5 μg/mL in 0.9% sodium chloride solution packaged in polypropylene syringes was studied. Methods. Samples of fentanyl 5 μg (as the citrate) per milliliter in 0.9% sodium chloride injection were prepared and assess
Autor:
Susan V McCluskey
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 65(12)
Purpose. The sterilization of glycerin is described. Summary. Glycerin is used in a wide variety of pharmaceutical formulations, including oral, otic, ophthalmic, topical, and parenteral preparations. Of the myriad uses for glycerin, some require a s
Autor:
McCluskey SV; Susan V. McCluskey, B.S.Pharm., is Pharmacy Production Laboratory Pharmacist, Mayo Clinic Rochester, Rochester, MN. Brian Gardner, Pharm.D., is Clinical Coordinator, Pediatrics, Kentucky Children's Hospital, Lexington. Kevin K. Graner, B.S.Pharm., is Pediatric Pharmacy Services Supervisor, Mayo Clinic Rochester. Nicole Vu, Ph.D., is Scientific Director, Analytical Research Laboratories, Oklahoma City, OK. mccluskey.susan@mayo.edu., Gardner B; Susan V. McCluskey, B.S.Pharm., is Pharmacy Production Laboratory Pharmacist, Mayo Clinic Rochester, Rochester, MN. Brian Gardner, Pharm.D., is Clinical Coordinator, Pediatrics, Kentucky Children's Hospital, Lexington. Kevin K. Graner, B.S.Pharm., is Pediatric Pharmacy Services Supervisor, Mayo Clinic Rochester. Nicole Vu, Ph.D., is Scientific Director, Analytical Research Laboratories, Oklahoma City, OK., Graner KK; Susan V. McCluskey, B.S.Pharm., is Pharmacy Production Laboratory Pharmacist, Mayo Clinic Rochester, Rochester, MN. Brian Gardner, Pharm.D., is Clinical Coordinator, Pediatrics, Kentucky Children's Hospital, Lexington. Kevin K. Graner, B.S.Pharm., is Pediatric Pharmacy Services Supervisor, Mayo Clinic Rochester. Nicole Vu, Ph.D., is Scientific Director, Analytical Research Laboratories, Oklahoma City, OK., Vu N; Susan V. McCluskey, B.S.Pharm., is Pharmacy Production Laboratory Pharmacist, Mayo Clinic Rochester, Rochester, MN. Brian Gardner, Pharm.D., is Clinical Coordinator, Pediatrics, Kentucky Children's Hospital, Lexington. Kevin K. Graner, B.S.Pharm., is Pediatric Pharmacy Services Supervisor, Mayo Clinic Rochester. Nicole Vu, Ph.D., is Scientific Director, Analytical Research Laboratories, Oklahoma City, OK.
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2015 Aug 01; Vol. 72 (15), pp. 1292-7.